ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978